Federal Express (FDX) reported earnings last Thursday. Revenues were off 20% from the year ago period and net income 53%, though EPS of 58 cents a share was well above previous guidance. FedEx talked some about recovery and CEO Fred…
Really good “Ahead of the Tape” WSJ column by Mark Gongloff from Friday: “Investors, It Pays to Mind the GAAP Gaps”. He discusses the widening gap between operating earnings and GAAP earnings over the last 15 years. From the chart,…
NOTE: Every week I write a Client Note for my clients. For a limited time, I am allowing non-clients to sign up and receive the Client Note. You can sign up at the top right hand corner of the website. …
Harley Davidson (HOG) reported 2nd quarter earnings before the open this morning, and while the stock is rallying powerfully today big problems are lurking beneath the surface. Worldwide retail sales of Harleys decreased 30% compared to the year ago period…
Intel’s second quarter results reflect improving conditions in the PC market segment. – Paul Otellini, CEO, Intel Everybody is gonzo about Intel’s (INTC) second quarter earnings report after today’s close but I just don’t see what’s so great about it. They…
The less-worse trade is in the late innings. We’re at valuation levels where things have to start growing in order to maintain momentum in the stock. – Mitchell Speiser (subscription required), Analyst, Buckingham Research, who has a Sell rating on PF…
It was psychologically painful in 1999 to give up making money on the way up and to expose yourself to the career risk that comes with looking like an old fuddy duddy. Similarly today, it is both painful and career…
Defense stocks have been getting crushed on the fear that Obama is going to cut back on defense spending. This has created some terrific opportunities. Take a look at this table of five of the largest US defense contractors: Company Market…
I don’t normally buy deep value, preferring instead an approach more like growth at a reasonable price, but three stocks with a real margin of safety have really caught my attention of late. (1) Pfizer (PFE). The giant drug maker has…
In yesterday’s (Wed, 2/25) WSJ, Wharton Professor Jeremy Siegel wrote an Op-Ed arguing that the way S&P calculates earnings is wrong and therefore stocks are much cheaper than most believe: “The S&P Gets Its Earnings Wrong” (subscription required – e-mail…